Timing, Predictive Factors, and Prognostic Value of Cerebrovascular Events in a Large Cohort of Patients Undergoing Transcatheter Aortic Valve Implantation
-
Published:2012-12-18
Issue:25
Volume:126
Page:3041-3053
-
ISSN:0009-7322
-
Container-title:Circulation
-
language:en
-
Short-container-title:Circulation
Author:
Nombela-Franco Luis1, Webb John G.1, de Jaegere Peter P.1, Toggweiler Stefan1, Nuis Rutger-Jan1, Dager Antonio E.1, Amat-Santos Ignacio J.1, Cheung Anson1, Ye Jian1, Binder Ronald K.1, van der Boon Robert M.1, Van Mieghem Nicolas1, Benitez Luis M.1, Pérez Sergio1, Lopez Javier1, San Roman José A.1, Doyle Daniel1, DeLarochellière Robert1, Urena Marina1, Leipsic Jonathon1, Dumont Eric1, Rodés-Cabau Josep1
Affiliation:
1. From the Quebec Heart and Lung Institute, Laval University, Quebec City, QC, Canada (L.N.-F., D.D., R.D., M.U., E.D., J.R.-C.); St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada (J.G.W., S.T., A.C., J.Y., R.K.B., J.L.); Thoraxcenter-Erasmus Medical Center, Rotterdam, the Netherlands (P.P.d.J., R.-J.N., R.M.v.d.B., N.V.M.); Angiografia de Occidente S.A., Cali, Colombia (A.E.D., L.M.B., S.P.); and Hospital Clinico Universitario de Valladolid, Valladolid, Spain (I.J.A.-S., J.L....
Abstract
Background—
The objective of this study was to evaluate the timing, predictive factors, and prognostic value of cerebrovascular events (CVEs) after transcatheter aortic valve implantation.
Methods and Results—
The study included 1061 consecutive patients who underwent transcatheter aortic valve implantation with a balloon-expandable (64%) or self-expandable (36%) valve. CVEs were classified as acute (≤24 hours), subacute (1–30 days), or late (>30 days). CVEs occurred in 54 patients (5.1%; stroke, 4.2%) within 30 days after transcatheter aortic valve implantation (acute in 54% of cases). The predictors of acute CVEs were balloon postdilation of the valve prosthesis (odds ratio, 2.46; 95% confidence interval,1.07–5.67) and valve dislodgment/embolization (odds ratio, 4.36; 95% CI, 1.21–15.69); new-onset atrial fibrillation (odds ratio, 2.76; 95% CI, 1.11–6.83) was a predictor of subacute CVEs. Late CVEs occurred in 35 patients (3.3%; stroke, 2.1%) at a median follow-up of 12 months (3–23 months). The predictors of late CVEs were chronic atrial fibrillation (2.84; 95% CI, 1.46–5.53), peripheral vascular disease (hazard ratio, 2.02; 95% CI, 1.02–3.97), and prior cerebrovascular disease (hazard ratio, 2.04; 95% CI, 1.01–4.15). Major stroke was associated with 30-day (odds ratio, 7.43; 95% CI, 2.45–22.53) and late (hazard ratio, 1.75; 95% CI, 1.01–3.04) mortality.
Conclusions—
In a large cohort of patients undergoing transcatheter aortic valve implantation, the rates of acute and subacute CVEs were 2.7% and 2.4%, respectively. While balloon postdilation and valve dislodgment/embolization were the predictors of acute CVEs, new-onset atrial fibrillation determined a higher risk for subacute events. Late events were determined mainly by a history of chronic atrial fibrillation and peripheral and cerebrovascular disease. The occurrence of major stroke was associated with increased early and late mortality. These results provide important insights for the implementation of preventive measures for CVEs after transcatheter aortic valve implantation.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
370 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|